PUBLISHER: Grand View Research | PRODUCT CODE: 1888672
PUBLISHER: Grand View Research | PRODUCT CODE: 1888672
The global genetic toxicology testing market size was valued at USD 1.62 billion in 2024 and is projected to reach USD 4.53 billion by 2033, expanding at a CAGR of 12.13% from 2025 to 2033. The industry is increasing due to several factors, including the growing prevalence of cancer, breakthroughs in genomics technology, research and development in the chemical, pharmaceutical, and biotechnology industries, the shift toward precision and personalized medicine, and increasing public awareness of the health risks associated with exposure to genotoxic agents.
Technological Advancements
The market for genetic toxicology testing is driven largely by technological advancements, which are transforming conventional testing paradigms and enhancing the precision, speed, and predictive value of genotoxic evaluations. By allowing for the simultaneous testing of thousands of samples, the integration of high-throughput screening (HTS) platforms has greatly accelerated compound evaluation, cutting costs and development timelines.
Moreover, the market's potential for growth has been further enhanced by the integration of artificial intelligence (AI) and machine learning (ML) into toxicology testing. In addition to increasing testing efficiency, this shift toward data-driven, computational toxicology is also aligned with international regulatory efforts that support non-animal, in silico, and in vitro testing methods.
Cosmetic and Chemical Safety Assessment
As consumers and regulatory bodies place a greater emphasis on product safety and sustainability, the growing demand for genetic toxicology testing is largely driven by the expanding sectors of cosmetics, agrochemicals, and industrial chemicals. The need to assess the potential mutagenic and carcinogenic effects of chemicals and cosmetic ingredients on human health and the environment is increasing as their production expands globally.
Moreover, manufacturers are being compelled to invest in thorough genotoxicity evaluations due to growing consumer awareness of product safety and the growing demand for "clean," non-toxic, and environmentally friendly formulations. To evaluate DNA damage, chromosomal abnormalities, and mutagenic potential in complex formulations, businesses utilize sophisticated cell-based assays, 3D tissue models, and microfluidic systems.
Global Genetic Toxicology Testing Market Report Segmentation
This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global genetic toxicology testing market report on the basis of product, type, assay, application, and region: